Is offering:

7,042,254 shares of common stock
at $0.71 per share
for gross offering proceeds of $5,000,000
under Reg A+

More information is available at FlashFunders.com/EMT

FinTech Clearing LLC is acting as exclusive Placement Agent

---

SEC Legend-Regulation A+ Offerings
An Offering Circular regarding Electromedical Technologies has been filed with the Securities and Exchange Commission (SEC). The SEC has qualified Electromedical Technologies offering circular, which only means that we may make sales of the Securities described in its offering circular. It does not mean that the SEC has approved, passed upon the merits, or passed upon the accuracy of completeness of the information in the Electromedical Technologies' Offering Circular. You may obtain copies of the offering circulars for Electromedical Technologies here.

Liquidity Risk-Regulation A+ Offerings
An investment in Electromedical Technologies have a high degree of risk including the lack of listed market for its securities, as well as other risks common to Regulation A+ investments generally, including, but not limited to, a small equity market capitalization and lack of public float, which may impair the liquidity of these investments. Electromedical Technologies can make no assurance about the success of its products, licensing or marketing efforts, or their ability to qualify for a listing on a national, or any other, securities exchange; consequently, investors in Electromedical Technologies may lose some or all of their investments.

Forward-Looking Statements
We make statements in this press release that are considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend for these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement in this press release for purposes of complying with those safe harbor provisions. Similar statements are made in the Offering Circulars or offering memoranda of Electromedical Technologies. These forward-looking statements reflect , as applicable, our or Electromedical Technologies' current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to Electromedical Technologies or us and on assumptions Electromedical Technologies or we have made. Although Electromedical Technologies or we believe that our plans, intentions, expectations, strategies and prospects as reflected in our suggested by those forward-looking statements are reasonable, Electromedical Technologies or we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond Electromedical Technologies ' or our control. For further discussion of the factors that could affect outcomes, please refer to the risk factors set forth in the “Risk Factors” section of the Final Offering Circular of Electromedical Technologies' Regulation A+ Offering. Electromedical Technologies or we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.